Metronidazole vs. Cipro

See how Metronidazole and Cipro compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Metronidazole targets anaerobic bacteria and parasites, while Cipro targets aerobic gram-negative bacteria, so the two treat different infections and are rarely interchangeable.

  • Metronidazole requires avoiding alcohol during and after treatment, while Cipro carries a boxed warning for tendon rupture, nerve damage, and other serious reactions.

  • Both are inexpensive generic antibiotics, but only a clinician can determine which one matches the specific infection and bacteria involved.

Metronidazole vs. Cipro Drug Summary

Metronidazole

Metronidazole is a nitroimidazole antibiotic that treats certain anaerobic bacterial and parasitic infections, including trichomoniasis, bacterial vaginosis, and intra-abdominal infections. It's usually taken as an oral tablet or capsule, though it also comes in IV, topical gel, and vaginal gel forms depending on the infection.

Cipro

Cipro (ciprofloxacin) is a fluoroquinolone antibiotic used for urinary tract infections, certain respiratory and skin infections, and other bacterial infections when other options aren't appropriate. It's taken as an oral tablet, usually every 12 hours, with treatment length depending on the infection.

Metronidazole vs. Cipro Side Effects

Metronidazole

Most common
Nausea (most common)
Diarrhea (commonly reported)
Headache (commonly reported)
Metallic taste (commonly reported)

Cipro

Most common
Nausea (up to 2.7%)
Diarrhea (up to 4.8%)
Vomiting (up to 4.8%)
Rash (up to 1.8%)

Metronidazole vs. Cipro Dosage

Metronidazole

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 250 mg 3x daily Days 1-7
Maximum dose 500-750 mg 3x daily If needed
Dose changes 2 increases As tolerated

Cipro

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 250 mg every 12 hrs At the start
Maximum dose 750 mg every 12 hrs If needed
Dose changes 2 increases As tolerated

Metronidazole vs. Cipro Indications

Metronidazole

Metronidazole is FDA-approved for trichomoniasis, amebiasis, bacterial vaginosis, and infections caused by anaerobic bacteria, including certain intra-abdominal and liver abscesses. Doctors also prescribe it off-label, often combined with other drugs, for H. pylori infections and C. diff colitis.

  • Trichomoniasis (symptomatic or asymptomatic)

  • Bacterial vaginosis

  • Amebiasis, including liver abscess

  • Intra-abdominal infections and abscesses

  • Anaerobic bacterial infections

Cipro

Cipro is FDA-approved for urinary tract infections, certain respiratory and skin infections, bone and joint infections, and some intra-abdominal infections, along with plague and anthrax exposure. Because of its serious side effect risks, the FDA advises reserving it for milder infections only when no other treatment option works.

  • Urinary tract infections (complicated or not)

  • Skin, bone, and joint infections

  • Certain respiratory infections and sinusitis

  • Intra-abdominal infections (with metronidazole)

  • Plague and anthrax exposure (prophylaxis)

Metronidazole vs. Cipro Pros and Cons

Metronidazole

Metronidazole has decades of use as a first-line treatment for trichomoniasis and bacterial vaginosis, with an affordable generic price across multiple forms. Its main drawbacks are the need to avoid alcohol during treatment and a carcinogenicity warning based on animal studies.

Pros

  • First-line therapy for trichomoniasis and bacterial vaginosis

  • Available in oral, IV, topical, and vaginal forms

  • Off-patent since 1982 with a long safety track record

  • Some infections need only a single-day or short course

Cons

  • Must avoid alcohol during and for days after treatment

  • Boxed warning for carcinogenicity seen in animal studies

  • Contraindicated with disulfiram or Cockayne syndrome

  • Not active against the aerobic bacteria that cause most UTIs

Cipro

Cipro offers broad coverage against gram-negative bacteria and short treatment courses for uncomplicated UTIs, with oral and IV options for more serious infections. Its boxed warning covers tendon, nerve, and CNS risks, so the FDA limits its use in some milder infections to cases with no other options.

Pros

  • Broad coverage against gram-negative bacteria like E. coli

  • Just a 3-day course for uncomplicated UTIs

  • Oral and IV forms allow step-down therapy

  • Widely available as an inexpensive generic

Cons

  • Boxed warning for tendon rupture and tendinitis

  • Risk of peripheral neuropathy and CNS effects

  • Can exacerbate myasthenia gravis and cause phototoxicity

  • FDA restricts use in sinusitis, bronchitis, and simple UTIs

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.